Sean A. McCarthy - 30 Sep 2019 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
President and CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Issuer symbol
CTMX
Transactions as of
30 Sep 2019
Net transactions value
$0
Form type
4
Filing time
08 Jun 2021, 13:10:22 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Gift $0 -4,500 -37% $0.000000 7,809 30 Sep 2019 Direct F1, F2
holding CTMX Common Stock 193,118 30 Sep 2019 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,006 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 31, 2021 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 Amount of securities directly held has been adjusted to reflect the transfer of (i) 2,473 shares pursuant to a domestic relations order on July 9, 2018, (ii) 193,118 shares to Sean A. McCarthy 2018 Trust.
F3 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.